Oral Selective Estrogen Receptor Degrader After Endocrine Therapy With a Cyclin-Dependent Kinase 4/6 Inhibitor.

Subjects

Subjects :

Humans
Female
Cyclin-Dependent Kinase 4
Estrogen Antagonists
Cyclin-Dependent Kinase 6
Estrogen Receptor alpha
Protein Kinase Inhibitors adverse effects
Receptors, Estrogen
Breast Neoplasms drug therapy

Details

Language :

English

ISSN :

1527-7755

Volume :

40

Issue :

36

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Editorial & Opinion

Accession number :

36067450

Full Text :

https://doi.org/10.1200/JCO.22.01454